Clinical trial
Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute…
NCT00051753 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00051753 |
|---|---|
| Title | Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media |
| Official title | A Multicenter, Randomized, Comparative Study to Evaluate the Efficacy and Safety of Levofloxacin in the Treatment of Children Who Have Recurrent and/or Persistent Acute Otitis Media |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Otitis Media |
| Intervention type | Drug |
| Interventions | levofloxacin, amoxicillin/clavulanate |
| Enrollment | 1,643 |
| Start date | Nov 1, 2002 |
| Completion | May 1, 2005 |
| First posted | Jan 17, 2003 |
| Last update posted | Jan 10, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: